NRX Pharmaceuticals Cash from Financing (TTM) Analysis

NRX Pharmaceuticals Inc (NRXP)

3.25 +0.11 (+3.50%) USD | NASDAQ | Apr 26, 11:01

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	6.201M
September 30, 2023	17.44M
June 30, 2023	18.91M
March 31, 2023	11.78M
December 31, 2022	32.21M

Date	Value
September 30, 2022	22.09M
June 30, 2022	59.64M
March 31, 2022	72.01M
December 31, 2021	63.46M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

6.201M

Minimum

Dec 2023

72.01M

Maximum

Mar 2022

33.75M

Average

22.09M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks